These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 19255410)
1. APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Berlau DJ; Corrada MM; Head E; Kawas CH Neurology; 2009 Mar; 72(9):829-34. PubMed ID: 19255410 [TBL] [Abstract][Full Text] [Related]
2. Association of Qian J; Betensky RA; Hyman BT; Serrano-Pozo A Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840 [TBL] [Abstract][Full Text] [Related]
3. Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon2/epsilon2 genotype. Berlau DJ; Kahle-Wrobleski K; Head E; Goodus M; Kim R; Kawas C Arch Neurol; 2007 Aug; 64(8):1193-6. PubMed ID: 17698712 [TBL] [Abstract][Full Text] [Related]
4. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353 [TBL] [Abstract][Full Text] [Related]
5. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk. Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998 [TBL] [Abstract][Full Text] [Related]
6. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls. Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805 [TBL] [Abstract][Full Text] [Related]
7. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status. Reas ET; Triebswetter C; Banks SJ; McEvoy LK Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
9. APOE2: protective mechanism and therapeutic implications for Alzheimer's disease. Li Z; Shue F; Zhao N; Shinohara M; Bu G Mol Neurodegener; 2020 Nov; 15(1):63. PubMed ID: 33148290 [TBL] [Abstract][Full Text] [Related]
10. Neocortical β-amyloid area is associated with dementia and APOE in the oldest-old. Berlau DJ; Corrada MM; Robinson JL; Geser F; Arnold SE; Lee VM; Kawas CH; Trojanowski JQ Alzheimers Dement; 2013 Nov; 9(6):699-705. PubMed ID: 23474043 [TBL] [Abstract][Full Text] [Related]
11. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice. Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773 [TBL] [Abstract][Full Text] [Related]
12. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600 [TBL] [Abstract][Full Text] [Related]
13. Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase. Woody SK; Zhou H; Ibrahimi S; Dong Y; Zhao L J Alzheimers Dis; 2016 Jun; 53(3):1015-31. PubMed ID: 27340853 [TBL] [Abstract][Full Text] [Related]
14. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Lamar M; Yu L; Rubin LH; James BD; Barnes LL; Farfel JM; Gaiteri C; Buchman AS; Bennett DA; Schneider JA Alzheimers Dement; 2019 Feb; 15(2):258-266. PubMed ID: 30321502 [TBL] [Abstract][Full Text] [Related]
15. AD and non-AD mediators of the pathway between the APOE genotype and cognition. Nichols E; Brickman AM; Casaletto KB; Dams-O'Connor K; George KM; Kumar RG; Palta P; Rabin JS; Satizabal CL; Schneider J; Pa J; La Joie R Alzheimers Dement; 2023 Jun; 19(6):2508-2519. PubMed ID: 36516004 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology. Baum L; Chen L; Ng HK; Pang CP Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880 [TBL] [Abstract][Full Text] [Related]
17. APOE ε4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Yu L; Boyle P; Schneider JA; Segawa E; Wilson RS; Leurgans S; Bennett DA Psychol Aging; 2013 Dec; 28(4):1015-23. PubMed ID: 23647000 [TBL] [Abstract][Full Text] [Related]
18. APOEε2 is associated with milder clinical and pathological Alzheimer disease. Serrano-Pozo A; Qian J; Monsell SE; Betensky RA; Hyman BT Ann Neurol; 2015 Jun; 77(6):917-29. PubMed ID: 25623662 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort. Berge G; Sando SB; Rongve A; Aarsland D; White LR J Neurol Neurosurg Psychiatry; 2014 Nov; 85(11):1227-31. PubMed ID: 24639435 [TBL] [Abstract][Full Text] [Related]
20. Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice. East BS; Fleming G; Peng K; Olofsson JK; Levy E; Mathews PM; Wilson DA Neuroscience; 2018 Jun; 380():103-110. PubMed ID: 29678753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]